Covid-19 vaccine immunogenicity in people living with HIV-1

INTRODUCTION: COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. Although they have proven to be very effective in the general population, little is known about their efficacy in immunocompromised patients. HIV-infected individuals’ response to vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Nault, Lauriane, Marchitto, Lorie, Goyette, Guillaume, Tremblay-Sher, Daniel, Fortin, Claude, Martel-Laferrière, Valérie, Trottier, Benoît, Richard, Jonathan, Durand, Madeleine, Kaufmann, Daniel, Finzi, Andrés, Tremblay, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069249/
https://www.ncbi.nlm.nih.gov/pubmed/35568588
http://dx.doi.org/10.1016/j.vaccine.2022.04.090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069249/
https://www.ncbi.nlm.nih.gov/pubmed/35568588
http://dx.doi.org/10.1016/j.vaccine.2022.04.090

Ejemplares similares